covid-19-sidebar Archives | Future Medicine India


Zydus Cadila gets USFDA nod for fulvestrant Injection

Ahmedabad-based pharmaceutical company Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market its Fulvestrant Injection, which is used in the treatment of breast cancer.

Read More..

New covid cases rise to 41,495 on Friday

India reported 44,671 new COVID-19 incidences on Thursday. With as many as 549 fatalities recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,23,244.


Biocon Biologics partners with Adagio Therapeutics to advance antibody treatment against COVID-19

Biocon Biologics has joined hands with the U.S. based Adagio Therapeutics to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets.


India delivers essential medical supplies to Bangladesh and Indonesia

India has recently delivered 300 oxygen concentrators and 100 metric tons of liquid medical oxygen to Indonesia to help the country fight rising cases of coronavirus infection. At the same time, Indian Railways delivered 200 metric tonnes of liquid medical oxygen (LMO) to Bangladesh in 10 containers via the Oxygen Express.


Moolchand hospital reports spike in neurological cases in post-COVID patients

Moolchand Hospital, Delhi has recorded a rise in neurological issues, including emergency cases of brain haemorrhage, among post-COVID-19 patients, it said in a statement.


Mpower initiates free virtual COVID grief support groups

The mental health organisation, Mpower – The Centre, in Kolkata has come forward to offer support to those in grief and bereavement during Covid-19.


Lung function improves in three months post Covid-19: Study

A study by doctors at the Kokilaben Dhirubhai Ambani Hospital showed that the majority of Covid-19 patients, even those with severe Covid-19-related pneumonia, are likely to show signs of improvement in the lungs, both structurally and functionally within three months.